Stock Screener App

無料 -

インストール

3.82

0.68% -0.0261

Genenta Science Spa Adr (GNTA)

概要ニュース株価時系列ディスカッション予測

Genenta Science Spa Adr (GNTA) 最新ニュース

Applying sector rotation models to Altice USA Inc.Free Risk Managed Intraday Trade Alerts - Newser

Genenta Science S.p.A. to Terminate Dedicated Suite Agreement with AGC Biologics - MSN

Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX) and Gilead Sciences (GILD) - The Globe and Mail

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Esperion (ESPR) - The Globe and Mail

Analysts Offer Insights on Healthcare Companies: NextCure (NXTC), Lexaria Bioscience (LEXX) and Travere Therapeutics (TVTX) - The Globe and Mail

Genenta Science stock maintains Buy rating as Temferon shows promise in GBM - Investing.com

Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar - GlobeNewswire Inc.

Genenta secures $21.9 million for cancer drug trial By Investing.com - Investing.com South Africa

Genenta secures €20M in mandatory convertible bond deal - Investing.com India

Genenta secures €20M in mandatory convertible bond deal By Investing.com - Investing.com South Africa

Genenta secures $21.9 million for cancer drug trial - Investing.com India

Genenta Science Secures €20 Million Convertible Bond Financing for Oncology Research - TipRanks

Genenta Science Secures €20 Million Financing to Boost Cancer Therapy Development - TipRanks

Oncology Breakthroughs: How Cancer Research Is Advancing in 202527.02.25News - Ariva

Genenta Science announces amendment to pact with AGC Biologics - Yahoo Finance

Genenta Science Enhances Manufacturing Agreement with AGC Biologics - TipRanks

Genenta Science Announces Shareholder Meeting - TipRanks

symbol__ Stock Quote Price and Forecast - CNN

10 Best Italian Stocks To Buy Now - Yahoo Finance

INCY

$75.59

0.93%

RPRX

$37.11

0.84%

INSM

$108.69

1.31%

SMMT

$27.07

2.65%

BNTX

$107.34

0.15%

ONC

$299.01

0.70%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | エドガーでオープン | ロイターで開く